E78 Partners

MARCH 18, 2025

This trend is echoed in similar PE outlooks , emphasizing that rate cuts from 2024 highs have spurred improved valuations and renewed investor confidence. B2C experienced a resurgence, with deal volumes climbing 10.9% as firms held back from divesting in hopes of stronger valuations in 2025. Overall, deal value climbed 10.3%

Prioritization 52

Prioritization Valuation B2C Healthcare 52

E78 Partners

MARCH 19, 2025

This trend is echoed in similar PE outlooks , emphasizing that rate cuts from 2024 highs have spurred improved valuations and renewed investor confidence. B2C experienced a resurgence, with deal volumes climbing 10.9% as firms held back from divesting in hopes of stronger valuations in 2025. Overall, deal value climbed 10.3%

Prioritization 52

Prioritization Valuation B2C Healthcare 52

PYMNTS

JUNE 15, 2018

With the B2B eCommerce market towering over B2C’s in terms of transaction value — Forrester Research estimates the U.S. trillion valuation in the U.S. With payments accelerating and globalizing, the B2B eCommerce industry is taking a page out of B2C’s book. percent CAGR, versus 5.8 percent CAGR, respectively).

B2C 40

B2C B2B eCommerce Reconciliations 40

PYMNTS

MARCH 31, 2017

Mbiz won’t reveal exactly how much it recently raised, but according to COO and cofounder Ryn Hermawan, its latest funding round puts a valuation on the firm at about $75 million. The company offers a platform through which businesses and government agencies can manage their clouds and ensure compliance. eProcurement.

B2B 43

B2B B2C Startups Advertising 43

Barry Ritholtz

DECEMBER 10, 2024

These 10% are what’s driving the entire valuation. The other thing that’s different is, is that today the companies with the most spectacular valuation levels are private. We’ll buy the rest of it at a, a full valuation, which we did. ’cause it had been very much a kind of B2C phenomenon, right?

Technology 52

Technology Manufacturing Investments Education 52

Barry Ritholtz

NOVEMBER 4, 2024

But I think the reality is right now, we just have an overhang from, I certainly in my world, I can speak to healthcare and FinTech, a number of companies going public and then disappointing or valuation just being excessive compared to the maturity of the businesses. And drug costs. Nobody wants to be at a hospital.

Healthcare 52

Healthcare Investments Numbers Marketing 52